NewsPublic figure
What Michael C. Hall's Story Can Help Us Understand About Hodgkin Lymphoma
The Dexter star was treated for Hodgkin lymphoma in 2010, and that January his spokesman said it was in remission. Here is what Hodgkin lymphoma actually is.
A plain-language summary based on public reporting and trusted sources, linked below.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
One statement, in January 2010
On January 13, 2010, the Associated Press reported that Michael C. Hall, then 38 and starring in Dexter, was being treated for cancer.
His own statement was short. "I feel fortunate to have been diagnosed with an imminently treatable and curable condition, and I thank my doctors and nurses for their expertise and care."
A spokesman, Craig Bankey, said the cancer was Hodgkin lymphoma, that it was in complete remission, and that treatment would continue as planned. The date of diagnosis and the treating hospital were not released. Hall planned to return to filming later that year.
Variety reported in 2024 that he would return as Dexter Morgan in a sequel series, Dexter: Resurrection.
That is what he made public. We do not go past it.
A cancer named after a cell
Hodgkin lymphoma starts in the lymph system, the network of vessels and nodes that carries immune cells around the body.
What separates it from the many other lymphomas is a cell. Pathologists look for Reed-Sternberg cells, which are large and abnormal and carry a surface marker called CD30. That marker later became a drug target.
NCI splits the disease in two. Classic Hodgkin lymphoma is the common form. Nodular lymphocyte-predominant Hodgkin lymphoma is a separate entity of B-cell origin.
The lab tells them apart by which proteins the cells display. Classic disease is CD15 positive, CD20 negative, CD30 positive, CD45 negative. The lymphocyte-predominant form runs the other way on every one of those four. Our page on Hodgkin versus non-Hodgkin lymphoma covers the wider family.
Who it tends to hit
NCI lists the risk factors plainly. Being in early adulthood, aged 20 to 39, is the largest one. A second, smaller peak comes after 65.
Being male raises risk. So does past infection with the Epstein-Barr virus in the teenage years or early childhood, and having a parent, sibling, or child with the disease.
SEER data matches. Hodgkin lymphoma is diagnosed most often between 20 and 34, and the median age at diagnosis is 38.
When to get checked
NCI's list of clinical features is specific, and the numbers in it matter.
- A painless swollen lymph node in the neck, the armpit, or the groin.
- Fever of 38 degrees Celsius, which is 100.4 Fahrenheit, or higher, with no clear cause.
- Drenching night sweats that keep coming back.
- Weight loss of 10 percent or more of body weight in the previous 6 months, without trying.
- Itching, especially after a bath or after drinking alcohol.
- Fatigue.
Fever, drenching night sweats, and that 10 percent weight loss have a name in the staging system. They are called B symptoms, and a stage is labeled A or B depending on whether they are present. NCI notes that fevers and weight loss carry the most weight, and that night sweats on their own do not worsen the outlook.
Most swollen nodes are infections. A node that stays up for weeks without an explanation is worth showing a doctor. Our page on night sweats and lymphoma covers the symptom in more detail.
How it is worked up
Diagnosis needs tissue. NCI recommends an excisional biopsy, meaning a whole node is removed rather than sampled with a needle, read by a pathologist.
After that comes a history focused on fever, night sweats and weight loss, a physical exam, and blood tests. Those include a complete blood count, an erythrocyte sedimentation rate, a chemistry panel, lactate dehydrogenase, uric acid and phosphorus.
Imaging is a CT of the neck, chest, abdomen and pelvis, or a PET-CT scan. HIV testing and hepatitis B and C serology are part of the standard workup.
Staging uses the Lugano classification, which replaced the older Ann Arbor system. Our page on lymphoma stages explains what stages I through IV describe.
What treatment involves
NCI states that up to 90 percent of newly diagnosed patients can be cured with combination chemotherapy, radiation therapy, or both.
The long-standing regimen is ABVD: doxorubicin, bleomycin, vinblastine and dacarbazine. It replaced an older combination that carried a much higher risk of later leukemia. Ten years after ABVD, NCI puts the risk of acute myeloid leukemia at under 1 percent, against about 3 percent for the older regimen.
For disease that comes back, brentuximab vedotin is an antibody-drug conjugate aimed at CD30, the marker on those Reed-Sternberg cells. It is often used to reach a complete response before a stem cell transplant.
One detail worth knowing: NCI says treatment should relieve the fever, sweats and itching within days.
The group picture
SEER figures describe the United States population as a whole. They are not a forecast for one person.
Five-year relative survival for Hodgkin lymphoma is 89.3 percent for cases from 2016 to 2022. By stage it is 92.7 percent at stage I, 95.4 percent at stage II, 87.7 percent at stage III, and 82.8 percent at stage IV.
Stage IV sits above 80 percent. That is unusual among cancers, and it is why stage alone tells you less here than it does elsewhere. The American Cancer Society projects about 8,920 new cases and 1,100 deaths for 2026; SEER publishes that forecast rather than producing it.
What this does not mean
A high group survival rate is not a promise. Subtype, stage, age, and how the disease responds early all move an individual case.
The long-term side of this disease is real too. NCI tracks second cancers and heart and lung effects for decades after treatment, which is why survivorship follow-up continues long after remission.
Sources
- AP via CBS News, Michael C. Hall Treated for Cancer — https://www.cbsnews.com/news/michael-c-hall-treated-for-cancer/
- Variety, 'Dexter: Resurrection': Michael C. Hall to Return for Sequel Series — https://variety.com/2024/tv/news/dexter-resurrection-michael-c-hall-sequel-series-1236086112/
- NCI PDQ, Adult Hodgkin Lymphoma Treatment (Health Professional Version) — https://www.cancer.gov/types/lymphoma/hp/adult-hodgkin-treatment-pdq
- NCI PDQ, Adult Hodgkin Lymphoma Treatment (Patient Version) — https://www.cancer.gov/types/lymphoma/patient/adult-hodgkin-treatment-pdq
- SEER Cancer Stat Facts, Hodgkin Lymphoma — https://seer.cancer.gov/statfacts/html/hodg.html
How this article was prepared
An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.
The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Hodgkin lymphoma. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.